Physician

Brian Michael Connolly, MD

According to 2025 Medicare claims, Brian Connolly, MD (NPI: 1982011797) practices dermatology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from Calvert, MD. This provider's primary affiliated billing organization is ANNE ARUNDEL DERMATOLOGY LLC (NPI: 1063481703; TIN: 521415148) and primary practice location at 20678-3198. Connolly is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Connolly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,235 traditional Medicare patients, billed 7,914 HCPCS/CPT codes, and received $412,927 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 655 prescription claims across 296 beneficiaries totaling $102,300 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 105 records totaling $2,332. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $79,814 to $412,927. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $27,705 and ending at $102,300. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$206K$413K2018 Medicare payment: $79,814 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $235,528 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $136,989 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $90,765 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $85,307 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $29,548 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $412,927 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20185221,751$79,814
20191,2655,065$235,528
20208913,378$136,989
20214832,123$90,765
20224581,599$85,307
2023221767$29,548
20241,2357,914$412,927

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$263K$526K2015 Drug cost: $27,705 (USD; Tot_Drug_Cst)2016 Drug cost: $148,650 (USD; Tot_Drug_Cst)2017 Drug cost: $526,196 (USD; Tot_Drug_Cst)2018 Drug cost: $434,515 (USD; Tot_Drug_Cst)2019 Drug cost: $168,767 (USD; Tot_Drug_Cst)2020 Drug cost: $230,155 (USD; Tot_Drug_Cst)2021 Drug cost: $264,067 (USD; Tot_Drug_Cst)2022 Drug cost: $20,606 (USD; Tot_Drug_Cst)2023 Drug cost: $41,792 (USD; Tot_Drug_Cst)2024 Drug cost: $102,300 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155085$27,705
2016133349$148,650
2017133435$526,196
2018169451$434,515
2019321666$168,767
2020332779$230,155
2021214480$264,067
2022157339$20,606
202399209$41,792
2024296655$102,300

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths488557$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more702885$64
11102Biopsy of related skin growth, first growth241271$63
17000Destruction of precancer skin growth, 1 growth610752$35
17003Destruction of precancer skin growth, 2-14 growths5133,316$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate872,523$5,786
KetoconazoleKetoconazole1063,796$2,229
MetronidazoleMetronidazole16614$1,617
FluorouracilFluorouracil22652$1,540
Doxycycline HyclateDoxycycline Hyclate411,043$1,124

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.105$2,332ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brian Michael Connolly, MD?

Tedicare shows public-source Medicare data for Brian Michael Connolly, MD (NPI 1982011797), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Michael Connolly, MD have ACO affiliation data?

Brian Michael Connolly, MD is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Brian Michael Connolly, MD?

Brian Michael Connolly, MD is linked to ANNE ARUNDEL DERMATOLOGY LLC (billing NPI 1063481703) in the available physician profile data.

Does Brian Michael Connolly, MD have Open Payments data?

Brian Michael Connolly, MD has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.